MARKET

BLPH

BLPH

Bellerophon
NASDAQ

Real-time Quotes | Nasdaq Last Sale

14.87
+1.10
+7.99%
Closed 16:00 05/22 EDT
OPEN
13.90
PREV CLOSE
13.77
HIGH
15.07
LOW
13.33
VOLUME
382.72K
TURNOVER
--
52 WEEK HIGH
26.00
52 WEEK LOW
3.186
MARKET CAP
91.19M
P/E (TTM)
-3.8978
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BLPH stock price target is 31.67 with a high estimate of 35.00 and a low estimate of 30.00.

EPS

BLPH News

More
Bellerophon Therapeutics Announces Closing of $43.7 Million Public Offering of Common Stock and Concurrent Registered Direct Offering and Full Exercise of Option to Purchase Additional Shares
GlobeNewswire · 3d ago
61 Biggest Movers From Yesterday
Gainers Nano Dimension Ltd. (NASDAQ: NNDM) shares surged 341.7% to close at $3.40 on Tuesday. HENSOLDT and Nano Dimension achieved a major breakthrough in electronics 3D printing.
Benzinga · 5d ago
8 Biotechs Tapping Secondary Markets for $3 Billion
GuruFocus.com · 5d ago
Mid-Afternoon Market Update: NASDAQ Rises 70 Points; ShiftPixy Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 0.18% to 24552.63 while the NASDAQ rose 0.76% to 9304.91. The S&P also rose, gaining 0.21% to 2960.01.
Benzinga · 6d ago
44 Stocks Moving In Tuesday's Mid-Day Session
Gainers Nano Dimension Ltd. (NASDAQ: NNDM) jumped 85.8% to $1.43. HENSOLDT and Nano Dimension achieved a major breakthrough in electronics 3D printing.
Benzinga · 6d ago
DVAX, ABUS, ACB and SRNE among midday movers
Seeking Alpha - Article · 6d ago
Mid-Day Market Update: Crude Oil Up 2%; Bellerophon Therapeutics Shares Plummet
Midway through trading Tuesday, the Dow traded down 0.11% to 24569.40 while the NASDAQ rose 0.73% to 9302.01. The S&P also rose, gaining 0.19% to 2959.67.
Benzinga · 6d ago
Mid-Morning Market Update: Markets Mixed; Walmart Beats Q1 Expectations
Following the market opening Tuesday, the Dow traded down 0.31% to 24520.71 while the NASDAQ rose 0.60% to 9289.91. The S&P also rose, gaining 0.01% to 2954.11.
Benzinga · 6d ago

Industry

Biotechnology & Medical Research
+1.01%
Pharmaceuticals & Medical Research
+0.05%

Hot Stocks

Symbol
Price
%Change

About BLPH

Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing products at the intersection of drugs and devices that address medical needs in the treatment of cardiopulmonary diseases. The Company is focused on the development of its nitric oxide therapy for patients with pulmonary hypertension (PH), using its delivery system, INOpulse, with pulmonary arterial hypertension (PAH) as the lead indication. The Company's INOpulse device has a mechanism that delivers brief, targeted pulses of nitric oxide timed to occur at the beginning of a breath for delivery to the alveoli of the lungs, which minimizes the amount of drug required for treatment. INOpulse is designed to be compatible with many long-term oxygen therapy (LTOT) systems via nasal cannula delivery.
More

Webull offers kinds of Bellerophon Therapeutics Inc stock information, including NASDAQ:BLPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLPH stock news, and many more online research tools to help you make informed decisions.